Fred Richards
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
-
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Neutropenia and Cancer Infections
Papers in ⓘ
- Oncology 6
- Cancer Treatment and Pharmacology 3
- Colorectal Cancer Treatments and Studies 2
-
- Lymphoma Diagnosis and Treatment 4
- Genetic factors in colorectal cancer 1
- Co-authors
- RN Levy (1 shared paper)RB Davis (1 shared paper)Samuel Kopel (1 shared paper)Robert W. Carey (1 shared paper)Philip Schulman (1 shared paper)Harvey D. Preisler (1 shared paper)HC Hoagland (1 shared paper)Jeffrey J. Kirshner (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Cancer (1 paper)Investigational New Drugs (1 paper)JAMA (1 paper)Gynecologic Oncology (1 paper)
- Partner nations
- United States
In The Last Decade
Fred Richards
11 papers receiving 406 citations
Peers
Comparison fields: 5 of 53
- Hematology 228
- Oncology 188
- Genetics 57
- Public Health, Environmental and Occupational Health 99
- Pathology and Forensic Medicine 52
Countries citing papers authored by Fred Richards
This map shows the geographic impact of Fred Richards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Richards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Richards more than expected).
Fields of papers citing papers by Fred Richards
This network shows the impact of papers produced by Fred Richards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Richards. The network helps show where Fred Richards may publish in the future.
Co-authors
The 25 scholars most cited alongside Fred Richards, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1987 | 225 | |
| 2 | 1991 | 85 | |
| 3 | 1984 | 36 | |
| 4 | 1971 | 26 | |
| 5 | 1986 | 23 | |
| 6 | 1983 | 13 | |
| 7 | 1986 | 12 | |
| 8 | 1996 | 2 | |
| 9 | 1983 | 2 | |
| 10 | 1990 | 2 | |
| 11 | 1989 | 1 |
About Fred Richards
Fred Richards is a scholar working on Oncology, Pathology and Forensic Medicine, Epidemiology, Hematology and Infectious Diseases, having authored 11 papers that have together received 427 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (4 papers), Cancer Treatment and Pharmacology (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Antimicrobial Resistance in Staphylococcus (1 paper), Genetic factors in colorectal cancer (1 paper), Testicular diseases and treatments (1 paper), Cancer therapeutics and mechanisms (1 paper) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Hematology (228 citations), Oncology (188 citations), Genetics (57 citations), Public Health, Environmental and Occupational Health (99 citations) and Pathology and Forensic Medicine (52 citations). Fred Richards has collaborated with scholars based in United States. Frequent co-authors include RN Levy, RB Davis, Samuel Kopel, Robert W. Carey, Philip Schulman, Harvey D. Preisler, HC Hoagland, Jeffrey J. Kirshner, Karol H. Katz and Carol A. Davis. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Investigational New Drugs, JAMA and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.